This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Qing Li, PhD
Scientist, Antibody Discovery & Protein Engineering at AstraZeneca


Dr. Qing Li is a scientist at MedImmune/AstraZeneca, and her research focuses on antibody discovery and engineering, antibody drug conjugates (ADCs), half-life extension, tissue specific drug delivery, and gene therapy. Dr. Li received her PhD in chemistry from University of Minnesota, where she developed a novel method of engineering and preparation of Chemically Self-assembled Antibody Nanorings (CSANs) that can be used for drug delivery, imaging and cell surface engineering. Dr. Li completed post-doctoral training in Dr. Brent Iverson and Dr. George Georgiou’s lab at the University of Texas, Austin, where she co-developed a yeast-surface-display based high-throughput screening method of protease evolution for altered specificity and activity.

Agenda Sessions

  • Improving Antibody Efficacy by Putting Antibodies at the Site of Action